BNBX vs OXBR

The Advanced Deterministic Scorecard reveals a critically weak financial profile with a Piotroski F-Score of just 1/9, indicating severe deterioration in fundamental health. Despite a low Debt/Equity ratio of 0.10, the company is deeply unprofitable, with negative operating margins (-1653.71%), negative ROE (-274.19%), and collapsing revenue (YoY growth: -59.10%). Cash flow and earnings are negative and volatile, while the stock has lost nearly all value over the past year (-98.9%) and five years (-100%), far underperforming sector peers. The absence of Altman Z-Score and Graham Number calculations further underscores data insufficiency and lack of financial stability for traditional valuation.

OXBR exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. While the company shows strong top-line revenue growth of 36.5%, this is completely offset by catastrophic profitability, with a profit margin of -80.68% and an ROE of -41.19%. The stock is in a clear technical downtrend, losing over 51% of its value in the last year, and consistently misses earnings estimates by wide margins. Trading at a P/B of 0.95 suggests the market is pricing in the ongoing erosion of the company's book value.